𝔖 Bobbio Scriptorium
✦   LIBER   ✦

In vitro evaluation of gentamicin released from microparticles

✍ Scribed by M.J Blanco-Prı́eto; C Lecaroz; M.J Renedo; J Kunkova; C Gamazo

Book ID
108454102
Publisher
Elsevier Science
Year
2002
Tongue
English
Weight
71 KB
Volume
242
Category
Article
ISSN
0378-5173

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

In vitro and in vivo release of gentamic
In vitro and in vivo release of gentamicin from biodegradable discs
✍ Pavan Kumar Naraharisetti; Herman Chian Guan Lee; Yin-Chih Fu; Duu-Jong Lee; Chi 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 257 KB 👁 2 views

## Abstract Osteomyelitis is an infection of the bone and successful treatment involves the removal of the affected bone and the tissue by a surgical procedure following prolonged systemic and local antibiotic therapy for 4 to 6 weeks. The current local treatment is done by poly methyl methacrylate

Release of gentamicin from bone regenera
Release of gentamicin from bone regenerative materials: An in vitro study
✍ M. Teller; U. Gopp; H.-G. Neumann; K.-D. Kühn 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 454 KB 👁 2 views

## Abstract Antibiotic loading of bone regenerative materials is a promising way to protect augmentation procedures from infection during the resorption phase of bone substitutes. Especially in the early stage of implantation, it should protect the grafted site against microbiological pathogens. Th

Release mechanisms from gentamicin loade
Release mechanisms from gentamicin loaded poly(lactic-co-glycolic acid) (PLGA) microparticles
✍ Wolfgang Friess; Monika Schlapp 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 407 KB

To provide local gentamicin delivery for 1 week based on a biodegradable system, poly(lactic-co-glycolic acid) (PLGA) microparticles were developed utilizing a 50/ 50 blend of Resomer 1 RG 502H, an uncapped variety of 13.5 kD, and Resomer 1 RG 503, an endcapped polymer of 36.2 kD. The liberation mec